- Steven Safe
- Distinguished Professor of Veterinary Physiology and Pharmacology and of Biochemistry and Biophysics Syd Kyle Chair in Veterinary Medicine
- VB / Room 410
- Undergraduate Education
- B.S. Queens University (1962)
- Graduate Education
- D.Phil. Oxford University (1966)
- Postdoc. Oxford and Harvard Universities (1966-68)
- Joined Texas A&M in 1981
Molecular Biology of Endocrine Disruption Chemicals
The aryl hydrocarbon receptor (AhR) is a nuclear helix-loop-helix transcription factor which forms a ligand-induced nuclear heterodimer with the AhR nuclear translocator (Arnt) protein. Research in this laboratory is focused on the molecular mechanism of crosstalk between the AhR and estrogen receptor (ER) signaling pathways in which the AhR inhibits estrogen-induced gene expression. The antiestrogenic activities of some AhR agonists are also being developed as drugs for clinical treatment of breast and endometrial cancers in women. Research on estrogen-dependent gene expression in various cancer cell lines is focused on analysis of several gene promoters to determine the mechanisms of ERa and ERb action. This includes several genes that are activated through interactions of the ER with Sp1 protein and other DNA-bound transcription factors.
Jin, UH, Michelhaugh, SK, Polin, LA, Shrestha, R, Mittal, S, Safe, S et al.. Omeprazole Inhibits Glioblastoma Cell Invasion and Tumor Growth. Cancers (Basel). 2020;12 (8):.
Safe, S, Jayaraman, A, Chapkin, RS. Ah receptor ligands and their impacts on gut resilience: structure-activity effects. Crit. Rev. Toxicol. 2020; :1-11.
Mohankumar, K, Li, X, Sung, N, Cho, YJ, Han, SJ, Safe, S et al.. Bis-Indole-Derived Nuclear Receptor 4A1 (NR4A1, Nur77) Ligands as Inhibitors of Endometriosis. Endocrinology. 2020;161 (4):.
Kumaravel, S, Singh, S, Roy, S, Venkatasamy, L, White, TK, Sinha, S et al.. CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck Cancers. Am. J. Pathol. 2020;190 (4):900-915.
Nottingham, E, Sekar, V, Mondal, A, Safe, S, Rishi, AK, Singh, M et al.. The Role of Self-Nanoemulsifying Drug Delivery Systems of CDODA-Me in Sensitizing Erlotinib-Resistant Non-Small Cell Lung Cancer. J Pharm Sci. 2020;109 (6):1867-1882.
Karki, K, Wright, GA, Mohankumar, K, Jin, UH, Zhang, XH, Safe, S et al.. A Bis-Indole-Derived NR4A1 Antagonist Induces PD-L1 Degradation and Enhances Antitumor Immunity. Cancer Res. 2020;80 (5):1011-1023.
Garcia-Villatoro, EL, DeLuca, JAA, Callaway, ES, Allred, KF, Davidson, LA, Hensel, ME et al.. Effects of high-fat diet and intestinal aryl hydrocarbon receptor deletion on colon carcinogenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 2020;318 (3):G451-G463.
Karki, K, Li, X, Jin, UH, Mohankumar, K, Zarei, M, Michelhaugh, SK et al.. Nuclear receptor 4A2 (NR4A2) is a druggable target for glioblastomas. J. Neurooncol. 2020;146 (1):25-39.
Chatterjee, S, Walsh, EN, Yan, AL, Giese, KP, Safe, S, Abel, T et al.. Pharmacological activation of Nr4a rescues age-associated memory decline. Neurobiol. Aging. 2020;85 :140-144.
Park, H, Jin, UH, Orr, AA, Echegaray, SP, Davidson, LA, Allred, CD et al.. Isoflavones as Ah Receptor Agonists in Colon-Derived Cell Lines: Structure-Activity Relationships. Chem. Res. Toxicol. 2019;32 (11):2353-2364.